Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where T. Rutkowski is active.

Publication


Featured researches published by T. Rutkowski.


Radiotherapy and Oncology | 2011

THE ESTIMATION OF LATE RADIATION REACTION OF SALIVARY GLANDS IN PATIENTS WITH SQUAMOUS CELL CANCER IRRADIATED IN HEAD&NECK REGION – THE PROSPECTIVE STUDY

M. Goleń; A. Wygoda; T. Rutkowski; W. Przeorek; B. Pilecki; M. Hutnik; B. Lukaszczyk-Widel; K. Składowski; Z. Kolosza

Purpose: The purpose of this study is to estimate the late radiation toxicity of salivary glands in patients with squamous cell cancer irradiated by conventional (3D CRT) or accelerated method (CAIR or CB).The special goal there is to analyse the influence of method of contouring the glands on the values of accumulated doses. Materials: In 65 patients with pharyngeal and laryngeal cancer irradiated to total dose in range 62.5-72,O Gy the estimation of late radiation toxicity of salivary glands was provided. All patients were irradiated by conventional (3D CRT) or accelerated method (CAIR or CB). There were used two methods of contouring parotids: whole organs and whole parotids including superficial part. The late radiation reaction was estimated after 3, 6 and every 6 months after final treatment with using CTC version 3.0 classification. The non parametric Mann-Whitney and Spearman test was used for the estimation of relationships. Results: We have observed the middle level of xerostomia connecting with change of amount and consistency of saliva after irradiation. The contouring of whole parotids including superficial part of organ had significant influence on decrease of mean, median and modal doses in whole organs. In our material we had: mean doses=29,93 Gy, median doses=29,18 Gy and modal doses =28,85 for whole parotids. Conclusions: Xerostomy is the most troublesome symptom in patients with squamous cell cancer in H&N region. The contouring of whole parotids including superficial part had significant influence on decrease of mean, median and modal doses in whole organ in the correlation to the group of patients with contouring only whole parotids.This prospective study is being continued.


Radiotherapy and Oncology | 2007

Two accelerated radiation treatments have produced identical acute mucosal toxicity profile. an interim report on cair-2 phase III trial for head and neck cancer patients

K. Składowski; M. Hutnik; A. Wygoda; W. Sasiadek; T. Rutkowski; M. Goleń; B. Pilecki


Radiotherapy and Oncology | 2017

PO-123: Hypothyroidism after radiotherapy of head and neck – incidence and risk factors.

U. Dworzecka; A. Wygoda; T. Rutkowski; B. Pilecki; K. Składowski


Radiotherapy and Oncology | 2017

PO-101: Osteopontin (OPN) as an instant, predictive marker of tumour hypoxia in head and neck cancer patients

J. Mrochem-Kwarciak; T. Rutkowski; A. Wygoda; R. Deja; A. Hajduk; Ł. Boguszewicz; P. Widłak; K. Składowski


Radiotherapy and Oncology | 2015

PO-108: The role of circulating HPV-16 DNA detection in HNSCC patients treated by definitive radiation or chemo-radiation

A. Hajduk; T. Rutkowski; A. Mazurek; K. Składowski


Radiotherapy and Oncology | 2015

OC-0288: Intensity of pain, depression and anxiety affect outcome of radiation treatment in head and neck cancer patients

A. Heyda; K. Składowski; A. Hajduk; L. Boguszewicz; M. Hutnik; M. Kentnowski; B. Lukaszczyk-Widel; L. Michalecki; B. Pilecki; T. Rutkowski; A. Wygoda


Radiotherapy and Oncology | 2015

OC-007: Is accelerated radiotherapy alone equivalent to chemo-radiation in patients with moderate advanced HNSCC?

K. Składowski; A. Wygoda; M. Snetura; T. Rutkowski; L. Michalecki; A. Heyda; A. Hajduk; M. Kentnowski; B. Lukaszczyk-Widel; B. Maciejewski


Radiotherapy and Oncology | 2013

PO-102: Prognostic Value of Osteopontin and C-Reactive Protein for Patients with Head and Neck Cancer.

J. Mrochem-Kwarciak; T. Rutkowski; A. Hajduk; B. Hejduk; B. Maslyk; M. Hutnik; Z. Kolosza; P. Widłak; B. Bobek-Bilewicz; K. Składowski


Radiotherapy and Oncology | 2013

PO-0668: Tumor volume as an essential prognostic factor for radiotherapy outcome in patients with early laryngeal cancer

T. Rutkowski; A. Wygoda; B. Hejduk; R. Rutkowski; K. Składowski; B. Maciejewski


Radiotherapy and Oncology | 2012

EP-1204 MARKERS OF TREATMENT OUTCOME FOR PATIENTS WITH HEAD AND NECK CANCER WHO UNDERWENT RADIOTHERAPY

T. Rutkowski; J. Mrochem-Kwarciak; A. Hajduk; A. Wygoda; B. Lukaszczyk-Widel; M. Hutnik; W. Przeorek; B. Maslyk; B. Hejduk; K. Składowski

Collaboration


Dive into the T. Rutkowski's collaboration.

Top Co-Authors

Avatar

K. Składowski

Institute of Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge